Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheltens

Showing results (261-270 of 266) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 266 results.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
Pageof 27

Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
Pageof 27